Earlier onset of δ-retrovirus-induced leukemia after splenectomy

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Florins, Arnaud ^a   Reichert, Michal ^b   Asquith, Becca ^c   Bouzar, Amel Baya ^a   Jean, Geneviève ^a   François, Carole ^a   Jasik, Agnieszka ^b   Burny, Arsène ^a   Kettman, Richard ^a   Willems, Luc ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b NATIONAL VETERINARY RESEARCH INSTITUTE   (Poland)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PERFORIN; BROXURIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPLENIA; B LYMPHOCYTE; CANCER RISK; CD8+ T LYMPHOCYTE; CELL COUNT; CONTROLLED STUDY; IMMUNE RESPONSE; LEUKEMIA; LYMPHOCYTE PROLIFERATION; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; RETROVIRUS INFECTION; SPLENECTOMY; VIRUS REPLICATION; ANIMAL; ANIMAL DISEASE; BIOLOGICAL MODEL; CELL PROLIFERATION; DISEASE MODEL; IMMUNE SYSTEM; KIDNEY; KINETICS; METABOLISM; ONSET AGE; PRENATAL DEVELOPMENT; RETROVIRUS; SHEEP; THEORETICAL MODEL; VIROLOGY;

BOVINE LEUKEMIA VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1;

AGE OF ONSET; ANIMALS; BROMODEOXYURIDINE; CELL PROLIFERATION; DELTARETROVIRUS; DISEASE MODELS, ANIMAL; IMMUNE SYSTEM; KIDNEY; KINETICS; LEUKEMIA; MODELS, BIOLOGICAL; MODELS, THEORETICAL; SHEEP; SPLENECTOMY;

EID: 70349218608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006943     Document Type: Article

References (25)

1. Cullingford GL, Watkins DN, Watts AD, Mallon DF (1991) Severe late postsplenectomy infection. Br J Surg 78: 716-721.
2. Davidson RN, Wall RA (2001) Prevention and management of infections in patients without a spleen. Clin Microbiol Infect 7: 657-660.
3. Fotiadis C, Zografos G, Aronis K, Troupis TG, Gorgoulis VG, et al. (1999) The effect of various types of splenectomy on the development of B-16 melanoma in mice. Anticancer Res 19: 4235-4239.
4. Golomb HM, Vardiman JW (1983) Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement. Blood 61: 349-352.
5. Kotzin BL, Strober S (1980) Role of the spleen in the growth of a murine B cell leukemia. Science 208: 59-61.
6. Saji S, Sakamoto J, Teramukai S, Kunieda K, Sugiyama Y, et al. (1999) Impact of splenectomy and immunochemotherapy on survival following gastrectomy for carcinoma: covariate interaction with immunosuppressive acidic protein, a serum marker for the host immune system. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer. Surg Today 29: 504-510.
7. Hull CC, Galloway P, Gordon N, Gerson SL, Hawkins N, et al. (1988) Splenectomy and the induction of murine colon cancer. Arch Surg 123: 462-464.
8. Dietrich PY, Henry-Amar M, Cosset JM, Bodis S, Bosq J, et al. (1994) Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? Blood 84: 1209-1215.
9. Cadili A, de Gara C (2008) Complications of splenectomy. Am J Med 121: 371-375.
10. Tura S, Fiacchini M, Zinzani PL, Brusamolino E, Gobbi PG (1993) Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. J Clin Oncol 11: 925-930.
11. Chung CT, Bogart JA, Adams JF, Sagerman RH, Numann PJ, et al. (1997) Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 37: 405-409.
12. Kaldor JM, Day NE, Clarke EA, Van Leeuwen FE, Henry-Amar M, et al. (1990) Leukemia following Hodgkin's disease. N Engl J Med 322: 7-13.
13. Suzuki S, Uozumi K, Utsunomiya A, Ishitsuka K, Masamoto I, et al. (2008) Aggressive NK cell leukaemia after splenectomy: association with CD95-resistant memory T-cell proliferation and recalcitrant clinical course of haemophagocytic syndrome. Eur J Haematol 81: 236-241.
14. Loughran TP Jr, Starkebaum G, Clark E, Wallace P, Kadin ME (1987) Evaluation of splenectomy in large granular lymphocyte leukaemia. Br J Haematol 67: 135-140.
15. Gillet N, Florins A, Boxus M, Burteau C, Nigro A, et al. (2007) Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel antiretroviral therapies in human. Retrovirology 4: 18.
16. Willems L, Kettmann R, Dequiedt F, Portetelle D, Voneche V, et al. (1993) In vivo infection of sheep by bovine leukemia virus mutants. J Virol 67: 4078-4085.
17. Debacq C, Asquith B, Kerkhofs P, Portetelle D, Burny A, et al. (2002) Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep. Proc Natl Acad Sci U S A 99: 10048-10053.
18. Debacq C, Gillet N, Asquith B, Sanchez-Alcaraz MT, Florins A, et al. (2006) Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol 80: 9710-9719.
19. Asquith B, Debacq C, Florins A, Gillet N, Sanchez-Alcaraz T, et al. (2006) Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proc Biol Sci 273: 1165-1171.
20. Florins A, Gillet N, Asquith B, Debacq C, Jean G, et al. (2006) Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep. J Virol 80: 11998-12008.
21. Florins A, Gillet N, Asquith B, Boxus M, Burteau C, et al. (2007) Cell dynamics and immune response to BLV infection: a unifying model. Front Biosci 12: 1520-1531.
22. Lewis M, Swirsky D (2005) Spleen: consequences of lack of function. Encyclopedia of life sciences.
23. Seabrook TJ, Hein WR, Dudler L, Young AJ (2000) Splenectomy selectively affects the distribution and mobility of the recirculating lymphocyte pool. Blood 96: 1180-1183.
24. Endo Y, Ohta M, Shibata K, Kai S, Iwaki K, et al. (2008) Splenectomy for hypersplenism caused by adult T-cell leukemia: Report of a case. Surg Today 38: 1148-1151.
25. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, et al. (2009) Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 27: 453-459.